Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta.
about
Interleukin-1 in the pathogenesis and treatment of inflammatory diseasesIL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin GThe IL-1 cytokine family and its role in inflammation and fibrosis in the lungInterleukin-1 Family Cytokines in Liver DiseasesTreating rheumatological diseases and co-morbidities with interleukin-1 blocking therapiesMechanisms of epithelial wound detectionPrion pathogenesis in the absence of NLRP3/ASC inflammasomesAnti-Interleukin-1 Agents in Adult Onset Still's DiseaseDietary modulation of the microbiome affects autoinflammatory diseaseDissecting How CD4 T Cells Are Lost During HIV InfectionLocalization and functionality of the inflammasome in neutrophilsEngagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritisGlobal substrate profiling of proteases in human neutrophil extracellular traps reveals consensus motif predominantly contributed by elastaseThe NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistanceRIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKLIL-1beta processing in host defense: beyond the inflammasomes.Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cellsIL-17RA signaling amplifies antibody-induced arthritis.Nucleoside diphosphate kinase and flagellin from Pseudomonas aeruginosa induce interleukin 1 expression via the Akt/NF-κB signaling pathways.Caspase-1 modulates incisional sensitization and inflammationPathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions.Beyond canonical inflammasomes: emerging pathways in IL-1-mediated autoinflammatory diseaseMechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.Caspase-1: the inflammasome and beyond.[The etiology and management of gout].Revisiting caspases in sepsis.IL-1β and IL-18: inflammatory markers or mediators of hypertension?Deep tissue injury in development of pressure ulcers: a decrease of inflammasome activation and changes in human skin morphology in response to aging and mechanical load.Significant role of IL-1 signaling, but limited role of inflammasome activation, in oviduct pathology during Chlamydia muridarum genital infectionInnate and adaptive immune responses to cell death.Neutrophil IL-1β processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux.An expanding role for interleukin-1 blockade from gout to cancer.Caspase-1-independent interleukin-1β is required for clearance of Bordetella pertussis infections and whole-cell vaccine-mediated immunityElimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damageAutoinflammation: translating mechanism to therapy.Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection.Neutrophil serine proteases promote IL-1β generation and injury in necrotizing crescentic glomerulonephritis.Targeting the inflammasome in rheumatic diseases.IL-21-mediated non-canonical pathway for IL-1β production in conventional dendritic cells.
P2860
Q24606766-F9C060E6-2C62-4F2F-A4D2-E648F5D059EAQ24633495-20F267BC-2370-4664-B3FA-18679DEFE1B2Q26752849-C6E5A373-4CB0-4B44-B669-64C8384D424EQ26778553-36F92755-D335-4BAD-97E7-B869BCB2C262Q26799747-D8D7E4CD-1613-40D4-8E29-780AFD9B52F0Q26992155-1747550E-7464-4FFD-A394-90550852F692Q27316552-3EF44DDD-EC5B-461A-AF48-E3806A631E70Q27495968-E85BA1A6-348B-421F-88C0-25C33C2F3657Q28249017-BD823430-A4F5-4289-8153-902A51D831E6Q28274045-6BBEB478-7301-4AE5-9F55-0B45520ED4BDQ28305418-5C1B699B-09BB-4F11-A6C3-9AB0CD6044CCQ28384291-3B48CA9F-F40D-4DA4-B402-8303BB47D3F0Q28533695-3DF584CF-D363-4C42-86EC-D8510909EAECQ29616026-83E65482-0B4A-4479-A7C6-DB8E274F8EDFQ30623992-E8A9A261-467C-4701-9947-29330969CBFEQ33535878-4FC12BDB-5AF2-4E2A-8BD2-1A2EB956DD24Q33801215-30E56570-9224-4786-8578-4ED510C614C3Q33948890-EE4627A7-96BD-467A-B9D5-25E2EC78226EQ34058535-329B59F0-DDD2-4E04-BC6D-63059DED3D48Q34058874-6C897F21-BFCD-4E94-AA27-68890D38220DQ34154905-C37A45DB-7AFF-4801-82A9-E5A1856FE7FDQ34269827-191DBF54-AEEB-473E-9944-6F88A7BF5BB2Q34307642-E3AE7ABB-602B-4CF8-954D-95E747FC6365Q34322559-2F111814-6074-40CF-A913-700474FF1BCDQ34344861-BE43C52C-2D42-42A1-9C90-3C1504888D8BQ34636225-69714756-5833-45DA-8DEB-DA8C2E0D7A0FQ34662282-E51617FA-5B03-4CA6-AF0A-EA517C63EEDCQ34914125-25F4C51E-EF66-4304-9FA2-9B5866036DB5Q34962251-09E99CBD-0ABC-4A2B-AFB0-6097B4CEBCB6Q35064456-E2C19D8F-B285-4069-83AF-F4AA631C5DDAQ35205885-2D9B1A5F-1F23-4798-882A-D2CF49A34F2EQ35206149-32D5C858-F596-4C20-ABA9-6C11EEA2E59FQ35219001-1A516B4C-1FF9-4FAD-BF9F-66EC2B3E8BECQ35242597-40E27E0A-8A38-4084-92B0-6C49DBC97BE1Q35417136-EE235C28-8B90-4A70-B9FD-622D92CFE021Q35558406-B0C27D75-E74C-4360-BFCD-4994EAD04A4CQ35634587-F7297403-BF74-4E8D-9BAC-6F39B57ADE5AQ35804151-47D6E1F9-742E-45D1-8E61-47FD60287B5FQ35804717-ECF54C5C-E7AA-4C1C-A077-31D83E70CD48Q36015043-271A8C8E-B475-421F-ADB4-EE8A6C9932B0
P2860
Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Inflammatory arthritis in casp ...... f bioactive interleukin-1beta.
@en
type
label
Inflammatory arthritis in casp ...... f bioactive interleukin-1beta.
@en
prefLabel
Inflammatory arthritis in casp ...... f bioactive interleukin-1beta.
@en
P2093
P2860
P50
P356
P1476
Inflammatory arthritis in casp ...... f bioactive interleukin-1beta.
@en
P2093
Christine T Pham
Helmut Sparrer
Jos W M van der Meer
Leo A B Joosten
Mihai G Netea
Monique M A Helsen
Wim B van den Berg
P2860
P304
P356
10.1002/ART.25006
P577
2009-12-01T00:00:00Z